Professor of Psychiatry and Psychology
Washington University School of Medicine
St. Louis, Missouri
Dr. Freedland is a Professor of Psychiatry and Psychology at Washington University School of Medicine in St. Louis, and the Program Director of the 2023 NIH Summer Institute on Randomized Behavioral Clinical Trials. He has served on the faculty of the annual Summer Institute since 2007. He is an expert in the selection and design of comparators for health-related behavioral trials, the role of feasibility studies and pilot trials in behavioral intervention research, and definitions of clinical significance in behavioral trials. He chaired the NIH/OBSSR Expert Panel on Comparator Group Selection in Behavioral and Social Science Clinical Trials and was the principal developer of the Purpose-Guided Trial Design (PGTD) framework. He has also served on the Single-Site and Pilot Clinical Trials (SSPT) study section and the multicenter Clinical Trials Review Committee (CLTR) for the National Heart, Lung, and Blood Institute, in addition to other grant review committees and special emphasis panels. He has also been a principal investigator or co-investigator on both single-site and multicenter trials of behavioral interventions. His research focuses primarily on the role and treatment of depression, stress, anxiety, and self-care in patients with heart disease, and he has been involved in clinical research on patients with other chronic medical conditions as well. Dr. Freedland was an Associate Editor of Psychosomatic Medicine for over 10 years, chaired the Publications and Communications Council of the Society of Behavioral Medicine, is the Associate Editor for Behavioral Medicine for the Hogrefe series on Advances in Psychotherapy: Evidence-Based Practice, and recently ended his term as the Editor-in-Chief of Health Psychology. He is a fellow of the Academy of Behavioral Medicine Research, Association for Behavioral and Cognitive Therapies, American Heart Association, American Psychological Association, American Psychosomatic Society, and Society of Behavioral Medicine. He is a former member of the Council of the American Psychosomatic Society, past Chair of the American Heart Association’s Behavior Change Committee, past President of the Academy of Behavioral Medicine Research, founder of the Society of Behavioral Medicine’s Cardiovascular Disease Special Interest Group, and founder of the Behavioral Medicine Research Council
AMASS 2 - The ORBIT Model for Developing and Testing Health Related Behavioral Interventions
Thursday, November 16, 2023
1:00 PM – 5:00 PM PST
